Patents by Inventor Jonathan Boutell
Jonathan Boutell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240360503Abstract: The invention relates to methods for use in nucleic acid sequencing, in particular methods for use in concurrent sequencing.Type: ApplicationFiled: March 15, 2023Publication date: October 31, 2024Inventors: Gery VESSERE, Aathavan KARUNAKARAN, Come RACZY, Jeff GAU, Jonathan BOUTELL, Roberto ANDRES, Michael BUREK, Eli CARRAMI
-
Publication number: 20240352515Abstract: A method of base calling nucleobases of two or more polynucleotide sequence portions, wherein said polynucleotide sequence portions have been selectively processed such that an intensity of the signals obtained based upon the respective first nucleobase is greater than an intensity of the signals obtained based upon the respective second nucleobase.Type: ApplicationFiled: March 15, 2023Publication date: October 24, 2024Inventors: Gery VESSERE, Aathavan KARUNAKARAN, Come RACZY, Jeff GAU, Jonathan BOUTELL, Roberto ANDRES, Michael BUREK, Eli CARRAMI
-
Publication number: 20240309423Abstract: Automated methods conducted in a sequencing flowcell, and kits for reusing a flowcell, are provided herein. In some examples, an automated method conducted in a sequencing flowcell may include, at a surface of the sequencing flowcell coupled to a first moiety, using a reagent to decouple a first complex from the first moiety. In some examples, the first complex may include a second moiety which couples to the first moiety and a polynucleotide coupled to the second moiety. In some examples, the method may further include using a nuclease to polynucleotides in the sequencing flowcell. The method may include, after using the reagent and after using the nuclease, coupling a second complex to the first moiety. The second complex may include a third moiety which couples with the first moiety and an oligonucleotide coupled to the third moiety.Type: ApplicationFiled: March 5, 2024Publication date: September 19, 2024Applicant: Illumina, Inc.Inventors: Jonathan Boutell, Katharina Mueller-Ott, Jason Betley, Xiaolin Wu, Wayne George, Pietro Gatti Lafranconi, Andrew Brown
-
Publication number: 20240279733Abstract: The present disclosure is directed to decoupling library capture (template seeding) from cluster generation to optimise both processes. This is achieved by introducing orthogonality between the seeding and clustering primer.Type: ApplicationFiled: December 15, 2022Publication date: August 22, 2024Applicant: Illumina, Inc.Inventors: Fei Shen, Mathieu Lessard-Viger, Eric Brustad, Allison Meade, Esteban Armijo, Michael Howard, Jeffrey Fisher, Jonathan Boutell, Ramon Saracho, Olivia Ghazinejad, Seth McDonald, Lena Storms, Jeffrey Brodin
-
Publication number: 20240263229Abstract: The present disclosure is generally directed to strategies for template capture and amplification during sequencing.Type: ApplicationFiled: December 15, 2022Publication date: August 8, 2024Applicant: Illumina, Inc.Inventors: Xiaoyu Ma, Mathieu Lessard-Viger, Jeffrey Fisher, Jonathan Boutell
-
Publication number: 20240117424Abstract: Reusable flow cells for sequencing which exhibit signal intensity retention over numerous use cycles, the active surface of which contains poly-azide functional moieties, methods of treating flow cells surfaces with reagents to provide such poly-azide functional moieties, and reagents therefor.Type: ApplicationFiled: September 12, 2023Publication date: April 11, 2024Applicant: Illumina, Inc.Inventors: Jonathan Boutell, Wayne George, Xiaolin Wu
-
Publication number: 20240102067Abstract: This disclosure relates to novel mjresynthesis kits and methods, in particular for use in pairwise sequencing.Type: ApplicationFiled: September 25, 2023Publication date: March 28, 2024Applicant: Illumina, Inc.Inventors: Kay Klausing, Jonathan Boutell, Trina Osothprarop, Oliver Miller, Justin Robbins
-
Publication number: 20230348973Abstract: The present disclosure is generally directed to strategies for template capture and amplification during sequencing. In some examples, a solid support is used for template capture and amplification.Type: ApplicationFiled: March 30, 2023Publication date: November 2, 2023Applicant: ILLUMINA CAMBRIDGE LIMITEDInventors: Xiaoyu Ma, Mathieu Lessard-Viger, Eric Brustad, Jeffrey Fisher, Jonathan Boutell, Weihua Chang
-
Patent number: 11661627Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: GrantFiled: September 25, 2020Date of Patent: May 30, 2023Assignees: Illumina, Inc., Illumina Cambridge LimitedInventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
-
Publication number: 20220333178Abstract: A method for seeding and amplifying target nucleic acids derived from a sample in a cluster at a site on a surface of a substrate includes retaining at least a portion of the target nucleic acids in an inactive form that cannot seed to provide a relatively low concentration of active form target nucleic acids available for seeding. As the active form target nucleic acids seed on the surface of the substrate, they may be amplified. Because the concentration of active form target nucleic acids is low, the likelihood is low that a second active form target nucleic acid will seed at the same site within the same cluster before the first active form target nucleic acid is sufficiently amplified to dominate. Accordingly, the likelihood that the cluster will pass filters is increased relative to traditional seeding and amplification methods employing a higher concentration of active form target nucleic acids.Type: ApplicationFiled: March 21, 2022Publication date: October 20, 2022Inventors: Gary Mark Skinner, Geraint Evans, Niall Gormley, Jonathan Boutell, Matthew W. Kellinger, Michael Previte, Molly He
-
Publication number: 20210010071Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: ApplicationFiled: September 25, 2020Publication date: January 14, 2021Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
-
Patent number: 10808277Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: GrantFiled: December 15, 2017Date of Patent: October 20, 2020Assignees: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITEDInventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
-
Publication number: 20180187252Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: ApplicationFiled: December 15, 2017Publication date: July 5, 2018Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
-
Publication number: 20150050657Abstract: Provided herein is a method of selecting target nucleic acids on a support. The method includes providing a plurality of beads each bead comprising one or more oligonucleotides, providing a support with a plurality of primers with a sequence complementary to at least a portion of the oligonucleotides on the beads, contacting the beads with the support wherein the oligonucleotides on the beads bind to the primers on the support, performing an extension reaction by extending the primers on the support to produce capture oligonucleotides, contacting the support comprising the capture oligonucleotides with the target nucleic acids, and extending the capture oligonucleotides bound to target nucleic acids to produce target extension products comprising a sequence complementary to at least a portion of the target nucleic acids. Optionally, the method further includes amplifying the target extension products.Type: ApplicationFiled: May 28, 2013Publication date: February 19, 2015Applicant: Illumina Cambridge LimitedInventors: Roberto Rigatti, Jonathan Boutell
-
Publication number: 20080009420Abstract: The present invention is directed to a method for isothermal amplification of a plurality of different target nucleic acids, wherein the different target nucleic acids are amplified using universal primers and colonies produced thereby can be distinguished from each other. The method, therefore, generates distinct colonies of amplified nucleic acid sequences that can be analyzed by various means to yield information particular to each distinct colony.Type: ApplicationFiled: March 19, 2007Publication date: January 10, 2008Inventors: Gary Schroth, David Lloyd, Lu Zhang, Tobias Barrost, Roberto Rigatti, Jonathan Boutell